GGrantIndex
Sort

53,477 grants matching addiction

Maximizing Effectiveness of Integrated Treatment Approaches

$476,330
Michael S Kidorf · Johns Hopkins University · RC1 · FY2010 · DA

Validation of a Prenatal Alcohol and Drug Screening Tool

$476,322
Mary Anne Armstrong · Kaiser Foundation Health Plan · R01 · FY2008 · AA

Development of Dopamine D3 Ligands as Medications for Psychostimulant Addiction

$476,321
Subramaniam Ananthan · Southern Research Institute · R01 · FY2010 · DA

Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention

$476,257
Joy Marie Schmitz · University Of Texas Hlth Sci Ctr Houston · R01 · FY2016 · DA

Matching Services to Client Needs in Drug Court

$476,241
Treatment Research Institute, Inc. (Tri) · R01 · FY2004 · DA

Graduate Training in Systems and Integrative Biology

$476,231
Michael P Nusbaum · University Of Pennsylvania · T32 · FY2007 · GM

Graduate Training in Systems and Integrative Biology

$476,231
Michael P Nusbaum · University Of Pennsylvania · T32 · FY2008 · GM

Dental and medical office iMET to reduce teen tobacco, alcohol, and drug use

$476,221
John R Knight · Boston Children'S Hospital · RC1 · FY2010 · DE

Neurobiological Circuits of Gain and Loss During Risky Decision Making

$476,196
Gregory S. Berns · Emory University · R01 · FY2009 · DA

Inhibition of P13k and MEK Pathways in the Treatment of Lung Cancer

$476,188
Kwok Kin Wong · Dana-Farber Cancer Inst · R01 · FY2010 · CA

Genes Contributing to Opioid Abuse in Humans

$476,162
Kari Stefansson · Decode Genetics, Ehf · R01 · FY2010 · DA

Modified Behavioral Treatment for Cocaine Patients with Cognitive Deficits

$476,145
Efrat Aharonovich · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2008 · DA

Linking substance use genetics to circadian function using high-throughput genomics

$476,123
Andreas Robert Pfenning · Carnegie-Mellon University · R01 · FY2025 · DA

The Dopamine Synapse and Associative Learning

$476,058
David Sulzer · Columbia University Health Sciences · R01 · FY2025 · DA

Maintenance Treatment for Smoking Cessation

$476,042
Stanford University · R01 · FY2004 · CA

Preclinical development of a selective Orexin-1 receptor antagonist for treatment of cocaine addiction

$476,025
Craig Fox · C4x Discovery Ltd · R01 · FY2018 · DA

SBIRT for Substance Abuse in Mental Health Treatment Settings

$476,011
Mitchell P Karno · University Of California Los Angeles · R01 · FY2015 · DA

Multidisciplinary Training in the Biology of Alcohol Addiction

$476,010
Brian A McCool · Wake Forest University Health Sciences · T32 · FY2022 · AA

Role of specific cortico-basal ganglia pathways in animal models of addiction

$476,003
Susan Marie Ferguson · Seattle Children'S Hospital · R01 · FY2016 · DA

Characterizing the effects of family history of alcoholism on alcohol analgesia

$475,995
Michael E Robinson · University Of Florida · R01 · FY2022 · AA

CBT Supervisor's Toolkit: Phase II

$475,982
Diane E Sholomskas · Cbt4cbt, Llc · R44 · FY2013 · AA

Multisite Controlled Trial of Cocaine Vaccine (1of 6) Lead Site/ Houston Treatmen

$475,979
Thomas Richard Kosten · Baylor College Of Medicine · R01 · FY2012 · DA

Metals in Electronic Cigarette Aerosol

$475,975
Prudence Talbot · University Of California Riverside · R01 · FY2017 · DA

Metals in Electronic Cigarette Aerosol

$475,975
Prudence Talbot · University Of California Riverside · R01 · FY2016 · DA

Metals in Electronic Cigarette Aerosol

$475,975
Prudence Talbot · University Of California Riverside · R01 · FY2018 · DA